Home » Topics » Regulatory

Regulatory
RSS

FDA approves new indication for Byetta

Oct. 20, 2011

FDA approves Merck & Co.'s Juvisync

Oct. 10, 2011

FDA approves Lilly's Cialis for new indications

Oct. 7, 2011

Pfizer launches BeneFIX RTS in Europe

Oct. 4, 2011

Mucosta approved in Japan for dry eye syndrome

Sep. 27, 2011

FDA approves new indication for Soliris

Sep. 27, 2011

Japanese authorities extend indication of Venogloblulin

Sep. 27, 2011

Asahi Kasei Pharma clear to market osteoporosis therapy in Japan

Sep. 27, 2011

Remicade approved in U.S. for new indication

Sep. 26, 2011

Avastin approved for new indication in Japan

Sep. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 6, 2025.
Regenxbio’s Duchenne gene therapy data positive as shares falter
BioWorld
Regenxbio Inc.’s gene therapy in treating Duchenne muscular dystrophy (DMD) produced positive initial phase I/II results from its first five patients. However,...
EMA warns Ozempic linked to ‘very rare’ side effect
BioWorld
The EMA’s safety committee has issued a warning that the GLP-1 receptor agonist Ozempic (semaglutide, Novo Nordisk A/S) can cause an acute eye condition in which...
Aiatella secures €2M for AI-based cardiovascular imaging tech
BioWorld MedTech
Aiatella Oy secured €2 million (US$2.28 million) in funding for its AI-powered cardiovascular imaging technology. The funds will be used to conduct clinical...